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pen accessAbstract Background: The study aimed at evaluating the clinical efﬁciency of a ketofol-based
sedation procedure during awake craniotomy for varied surgical indications.
Methods: The study included 28 patients; 19 males and 9 females with mean age of
33.4 ± 9.3 years. All patients received propofol (0.5 mg/kg/h) and ketamine (0.5 mg/kg/h) infusion
mixture in 1:1 ratio. Conscious level was evaluated using the Modiﬁed Observer’s Assessment of
Alertness/Sedation scale and patients were maintained at level 3, at which the patients will respond
after their name is called loudly or repeatedly; otherwise patient was considered over-sedated. Intra-
operative (IO) monitoring included intracranial pressure (ICP), hemodynamic and respiratory
changes, brain status, whether slack or tense, the frequency of over-sedations and adverse events.
Duration of surgery, time till PACU transfer, total anesthesia time, postoperative (PO) complica-
tions and duration of hospital stay were reported. Patients’ satisfaction, on 0–10 score, about the
procedure used for awake sedation was inquired.
Results: Mean duration of surgery was 168.8 ± 19.4 min; mean time till PACU transfer after stop-
page of infusion was 11.1 ± 1.7 min for a mean anesthesia time of 179.9 ± 19.2 min. Three patients
had blood pressure changes, 4 had heart rate variability, 2 had respiratory depression and one had
SpO2 <90%. Two patients developed focal seizures, one had nausea and 2 patients were over-
sedated. Brain was tense in only 3 patients (10.7%). Four patients had PO transient neurological.com (H.A. Shehab).
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294 S.A. Abdou et al.deﬁcits, 3 patients had PO seizures and only 2 patients had recurrent attacks of nausea and vom-
iting; however, these complications responded to treatment. Mean hospital stay was 3.1 ± 1.1 days.
Mean satisfaction score was 9.1 ± 1.2; range: 6–10 with a satisfaction rate of 78.6%.
Conclusion: Conscious sedation during awake craniotomy using ketofol infusion mixture in 1:1
ratio was safe and efﬁcient with minor hemodynamic and respiratory events and rapid smooth
recovery proﬁle.
ª 2010 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.Table 1 Patients’ characteristics.
Total
Age (year) 33.4 ± 9.3 (21–56)
Gender; M:F 19:9
Body weight (kg) 76.3 ± 10.5 (59–92)
ASA grade
I 15 (53.6%)
II 13 (46.4%)
Lesion laterality
Left hemisphere 16 (57.1%)
Right hemisphere 12 (42.9%)
Presenting symptoms
Headache 22 (78.6%)
Motor deﬁcit 9 (32.1%)
Seizure 8 (64.3%)
Data are presented as mean ± SD, ratio and numbers; ranges and
percentages are in parenthesis.
Open access under CC BY-NC-ND license.1. Introduction
The progressive advances in the ﬁeld of neurodiagnosis and
neurosurgery opened the way for management of cases that
were previously considered unmanageable. However, these ad-
vances and multiplicity of techniques imposed a challenge on
the ﬁeld of neuroanesthesia that must accommodate the race
of advances in neurosurgery.
Awake anesthesia for neurosurgical procedures concerned
with surgical management of epilepsy proved successful and
became a routine for such surgeries [1,2]. A variety of anes-
thetic modalities became available to facilitate awake intraop-
erative examinations and cortical stimulation, which allow
more aggressive resection of tumors in functionally important
brain regions. Improving pharmacological agents especially
that maintained the patient conscious and allowed early com-
fortable recovery and the availability of multiple combinations
and variety of techniques freed the anesthetist’s hand for anes-
thetic manipulations for awake craniotomy procedures.
Multiple studies evaluated the safety of intravenous keta-
mine/propofol combination (‘‘ketofol’’) in the same syringe
for procedural sedation and analgesia; Santiveri et al. [3] found
low doses of ketamine associated with propofol improve punc-
ture conditions for performing a retrobulbar block without
increasing unwanted side effects. Willman and Andolfatto [4]
found ketofol procedural sedation and analgesia is effective
and appears to be safe for painful procedures in the emergency
department and reported few adverse events that were either
self-limited or responded to minimal interventions with rapid
recovery and staff and patients were highly satisﬁed.
Mustafaeva et al. [5] found the mixture of ketamine and
propofol has proved to be a safe and effective sedative; its
use provides not only a good position comfort, possible avoid-
ance of opioids, and no effect of ketamine on psychomotor
recovery, but also a more controlled sedation than when these
agents are used in the same doses alone during endoscopic
interventions into the digestive tract. Thus, the present study
aimed at evaluating the clinical efﬁciency of a ketofol-based
sedation procedure during awake craniotomy for varied surgi-
cal indications.
2. Patients and methods
After obtaining Local Ethical Committee approval of the
study protocol and fully informed written patients’ consent;
28 cooperative patients assigned for craniotomies for tumor
resection and are physically able to tolerate awake surgery
were enrolled in the study.
Patients with morbid obesity, chronic obstructive pulmon-
ary disease, complicated airway, history of allergy to local
anesthetics or drugs used in the study, confusion, communica-
tion difﬁculties, or extreme anxiety were excluded of the study.Patients had tumors involving signiﬁcant dural invasion which
cause signiﬁcant pain on resection or requires positioning
other than supine or needs prolonged operative time for more
than 4 h were not enrolled in the study.
The study included 28 patients; 19 males and 9 females with
mean age of 33.4 ± 9.3; range: 21–56 years. There were 15
ASA I, 13 ASA II patients. There were a total of 16 left hemi-
spheric tumors and 12 right hemispheric tumors. The patients
presented most frequently with headache followed by symp-
toms of hemiparesis and/or seizures in varied combinations
(Table 1).
No preoperative sedation was administered. On arrival to
the operating room intravenous access was established for
administration of intravenous ondanesetrone (8 mg), dexamet-
hazone (8 mg) and slow intravenous injection of phenytoin
250 mg. Routine monitoring included an electrocardiogram,
noninvasive arterial blood pressure, pulse oximetry, and end-
tidal carbon dioxide and respiratory rate measured via an oxy-
gen delivery nasal prongs. Supplemental oxygen was delivered
at 4 l/min.
All patients received IV midazolam 15 lg/kg after they were
placed on the operating table in the correct position for sur-
gery using extra cushions and padding to ensure maximum pa-
tient comfort. Then, all patients received the same sedation
solution using propofol (0.5 mg/kg/h) and ketamine (0.5 mg/
kg/h) infusion mixture in 1:1 ratio.
The sites of pin insertion for rigid head ﬁxation were inﬁl-
trated with local anesthesia (lidocaine 2% with 1:200,000 epi-
nephrine), after ﬁxation the infusion was brieﬂy stopped to
ensure patient comfort with head positioning and then re-
started. Conscious level was evaluated using the Modiﬁed
Observer’s Assessment of Alertness/Sedation scale [6], pa-
tients were maintained at level 3, at which the patients will
Table 2 Patients’ distribution according to intraoperative
events.
Total
Hemodynamic changes
Blood pressure
Hypertensive episodes (SBP >150 mmHg) 2 (7.1%)
Hypotensive episodes (SBP <90 mmHg) 1 (3.6%)
Within acceptable range 25 (89.3%)
Heart rate
Tachycardia (HR >110 beats/min) 3 (10.7%)
Bradycardia (HR <50 beats/min) 1 (3.6%)
Within acceptable range 24 (85.7%)
Respiratory events
Respiratory depression
No 26 (92.9%)
Occurred 2 (7.1%)
Desaturation (SpO2 <90%)
Occurred 1 (3.6%)
No 27 (96.4%)
Focal seizures
Occurred 2 (7.1%)
No 26 (92.9%)
Nausea and vomiting
Occurred 1 (3.6%)
No 27 (96.4%)
Over sedation
Occurred 2 (7.1%)
No 26 (92.9%)
Brain status
Slack 25 (89.3%)
Tense 3 (10.7%)
Data are presented as numbers and percentages are in parenthesis.
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wise patient was considered over-sedated. At any time during
the procedure when excessive pain was expected, such as the
inﬁltration of the local anesthetic into the pin sites and scalp,
additional anesthesia was given by increasing the infusion
rate. Maintenance IV ﬂuids consisted of normal saline at
the rate of 50–100 ml/h. Approximately 5 min before brain
mapping, infusion was discontinued, then infusion was re-
sumed for tumor resection and closure. All patients received
fentanyl 1–2 lg/kg for postoperative analgesia at the time of
skin closure. Patients were transferred to the post-anesthetic
care unit (PACU) for a 4-h stay before discharge to the
ward.
Intracranial pressure was recorded using Codman Micro
Sensor, Johnson & Johnson Medical Ltd. The Codman micro
sensor was calibrated to zero according to the manufacturer’s
instructions prior to placement, it is then inserted into deep
white matter, at a depth of 20–35 mm from the cortical surface
and a baseline reading is taken through a mini-burr hole done
under local anesthesia before starting of infusion. Intravenous
mannitol 0.5 g/kg was administered prior to skin incision. ICP
readings were recorded prior to initiation of infusion (base-
line), at time pin insertion, before opening of dura, after dural
closure and at end of surgery.
Intraoperative arterial blood pressure, heart rate, oxygen
saturation, and respiratory rate were monitored and managed
accordingly by manipulation of the infusion rate or adminis-
tration of supplemental intravenous ﬂuids. Also, the frequency
of over-sedated patients and intraoperative adverse events as
nausea, occurrence of focal seizures and respiratory depression
was reported. Intraoperative brain status; whether tense or
slack was documented and was arbitrarily abbreviated as yes
or no for slack brain status and was scored as yes = 1 and
no = 0.
Duration of surgery, time till PACU transfer and total
anesthesia time were recorded. Postoperative pain was treated
with IM non-steroidal anti-inﬂammatory drugs. Postoperative
complications and duration of hospital stay were also re-
ported. Patients’ satisfaction, on 0–10 score, about the proce-
dure used for awake sedation was inquired.
2.1. Statistical analysis
Obtained data were presented as mean ± SD, ranges, numbers
and ratios. Inter-group variability of hemodynamics and ICP
were analyzed using ANOVA test using the SPSS (Version
10, 2002) for Windows statistical package. P value <0.05
was considered statistically signiﬁcant.
3. Results
Mean duration of surgery was 168.8 ± 19.4; range: 150–
215 min, mean time till PACU transfer after stoppage of infu-
sion was 11.1 ± 1.7; range: 8–14 min for a mean anesthesia
time of 179.9 ± 19.2; range: 158–226 min.
Intraoperative events occurred in 15 patients (53.6%) and
included blood pressure changes in 3 patients (10.7%) and
heart rate variability in 4 patients (14.2%). Respiratory depres-
sion was encountered in 2 patients (7.1%) and intraoperative
peripheral blood desaturation with SpO2 <90% occurred in
one patient (3.6%). Focal seizures occurred in 2 patients(7.1%) and nausea occurred in only one patient (3.6%).
Throughout intraoperative course, 2 patients (7.1%) were
over-sedated due to increased dose of ketofol to combat the
recorded episode of hypertension and these two patients
were ready for discharge of theater at 12 and 14 min after
infusion stoppage. Tense brain status was encountered in 3
patients (10.7%), while in the other 25 patients brain was slack
(Table 2).
Mean ICP measures were signiﬁcantly lowered prior to
dural opening compared to both baseline and pin-insertion
measures. Mean ICP measures after dural closure and skin
closure showed non-signiﬁcant difference and patients were
discharged to PACU with ICP measures within normal range
(Table 3).
Postoperative transient neurological deﬁcits were recorded
in 4 patients, 3 patients had postoperative seizures and only
two patients had recurrent attacks of nausea and vomiting;
however, these complications responded to treatment
and did not recur. Mean hospital stay was 3.1 ± 1.1; range:
1–5 days.
Mean satisfaction score was 9.1 ± 1.2; range: 6–10; 4
patients found the sedation procedure unsatisfactory because
of prolonged time till transfer to PACU; 2 patients (7.1%)
scored their satisfaction by 6 and the other 2 patients (7.1%)
by 7. Another 2 patients (7.1%) scored their satisfaction by
Table 3 ICP measures (mmHg) recorded throughout obser-
vation period.
Mean ± SD Range
Baseline 25.2 ± 1.8 20.5–28.4
At time of pin insertion 25.9 ± 1.7 20.6–27.8
Prior to dural incision 17.3 ± 0.9 15.8–18.8
After dural closure 12.2 ± 1.6 9.8–14.8
At time of skin closure 11 ± 2.7 7.2–14.8
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Figure 1 Patient’s distribution according to satisfaction score
about the applied sedation procedure.
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(60.8%) scored it by 10 (Fig. 1) for a satisfaction rate of
78.6%.
4. Discussion
Considering the present study as a preliminary trial for evalu-
ation of the outcome of ketofol-based sedation for awake cra-
niotomy, the reported outcome as regards the total frequency
of intraoperative events (15 patients; 53.6%) was similar or
superior to that reported in the literature concerning various
modalities of conscious sedation for awake craniotomy; Man-
ninen et al. [7] reported a total incidence of intraoperative com-
plications/complaints of 56% with fentanyl/propofol and 64%
with remifentanil/propofol with non-signiﬁcant difference;
however, respiratory complications occurred in total of 9
(18%) patients; 5 with fentanyl and 4 with remifentanil com-
pared versus only 3 (10.7%) with ketofol in the current study.
Sinha et al. [8] reported intraoperative complications namely;
hypertension (19%), tight brain (14.2%), focal seizure
(9.5%), respiratory depression (7.1%), deep sedation (7.1%),
tachycardia (7.1%) and desaturation to <95% (4.8%) in a to-
tal of 42 patients underwent awake craniotomy under con-
scious sedation using fentanyl/propofol infusion.
Ketofol provided hemodynamic stability or minor changes
that were manifested as minimal number of patients showed
deviations from their baseline measures and maintenance of
ICP after closure of dura and skin closure within the normalrange without intraoperative episodes of increased ICP. These
data coincided with Akin et al. [9] who found a signiﬁcant de-
crease in mean arterial blood pressure in 11 patients (36.6%)
with propofol compared to 3 patients (10%) with ketofol dur-
ing cardiac catheterization in pediatric patients and concluded
that the addition of low-dose ketamine to propofol preserved
blood pressure without prolonging recovery or increasing the
incidence of adverse events. These results could be attributed
to the contradictory effect of both ketamine and propofol on
autonomic nervous system, ketamine being sympathomimetic
while propofol lessens this effect. A similar attribution was
provided by Timm et al. [10] who reported that even low-dose
S(+)-ketamine has a stimulatory effect on the cardiovascular
system, but this stimulatory effect is nulliﬁed in the presence
of a continuous propofol infusion at a dosage of more than
3 mg/kg BW/h, however, such high propofol dose used was
not the applied in the current study and this could explain
the occurrence of blood pressure changes occurred in 3 pa-
tients (10.7%) and heart rate variability in 4 patients (14.2%).
The reported mean time till PACU transfer after infusion
stoppage was 11.1 ± 1.7; range: 8–14 min which is coincident
with and superior to that previously reported in the literature;
15 min [4], 23.16 min [11], 10 min to ﬁrst purposeful response
[12], 14 minutes [13]. The shorter time till PACU transfer re-
ported in the current study could be attributed to the used dos-
age ratio and goes in hand with Erden et al. [14] who reported
12.1 ± 1 min with propofol 0.5 mg/kg and ketamine 0.5 mg/kg
and 13.8 ± 0.8 with propofol 0.5 mg/kg and ketamine
0.25 mg/kg.
The dosage ratio of propofol to ketamine in preparing keto-
fol infusion represents a challenge; Akin et al. [15] compared
propofol (1.5 mg/kg) to propofol (1.5 mg/kg) plus ketamine
(0.5 mg/kg) in a ratio of 3:1 and reported no cases of desatura-
tion with ketofol, but with propofol 4/30 experienced desatura-
tion and 6/30 had apnea, blood pressure and heart rate were
signiﬁcantly lower with propofol than ketofol and concluded
that the addition of low dose ketamine to propofol reduced
the risk of respiratory depression and the need for repeat med-
ication administration. Sharieff et al. [12] used propofol 1 mg/
kg and ketamine 0.5 mg/kg in a ratio of 2:1 for sedation for
closed reduction of forearm fractures in pediatrics and found
the combination provided effective sedation with rapid recov-
ery and no clinically signiﬁcant complications. Tosun et al. [16]
compared propofol 1.2 mg/kg and ketamine 1 mg/kg in a ratio
of 1.2:1 versus propofol/fentanyl in the same ratio and both
combinations provided effective sedation and analgesia during
dressing changes in pediatric burn patients, but propofol/keta-
mine combination was superior because of more restlessness in
patients given propofol/fentanyl.
These previously stated data spotlight on an ongoing trend
towards equalization of the ratio so as to minimize propofol-
related adverse events especially cardiovascular and respira-
tory events, thus the current study was based on the applica-
tion of ketofol infusion of propofol 0.5 mg/kg and ketamine
0.5 mg/kg in a ratio of 1:1. In support of the utility of such ra-
tio; Andolfatto and Willman [13] used intravenous ketofol
(mixed 1:1 ketamine/propofol) for emergency department pro-
cedural sedation and analgesia for primarily orthopedic proce-
dures and found sedation was effective in all patients, 3
patients (1.4%) had airway events requiring intervention, 2 pa-
tients (0.9%) had unpleasant emergence requiring treatment,
while all other adverse events were minor. Also, Erden et al.
Preliminary evaluation of ketofol-based sedation for awake craniotomy procedures 297[14] compared propofol 0.5 mg/kg and ketamine 0.5 mg/kg
versus propofol 0.5 mg/kg and ketamine 0.25 mg/kg and re-
ported no signiﬁcant differences between the two groups with
respect to hemodynamic data, oxygen saturation, or side-ef-
fects, however, the mean propofol dosage and the number of
over-sedated patients (sedation score >4) was higher in group
2 and recommend propofol 0.5 mg/kg and ketamine 0.5 mg/kg
which is associated with reduced rescue propofol requirements
and therefore less over-sedation. In support of the validity of
1:1 ketamine/propofol ratio, Rapeport et al. [17] used ‘‘keto-
fol’’ (ketamine 200 mg and propofol 200 mg) infusion in con-
junction with regional anesthesia for four high risk patients
and found ketofol safe and effective with the advantages in-
cluded analgesia, airway preservation, maintenance of sponta-
neous respiration, haemodynamic stability and rapid recovery.
In conclusion, ketofol (propofol 0.5 mg/kg and ketamine
0.5 mg/kg) provided safe and efﬁcient conscious sedation dur-
ing awake craniotomy with minor hemodynamic and respira-
tory events and rapid smooth recovery proﬁle. However,
wider scale studies are mandatory for establishment of these
results and dosage regimen.
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